Akimitsu Hirai
Fundador en FUNPEP COMPANY LIMITED .
Cargos activos de Akimitsu Hirai
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
FUNPEP COMPANY LIMITED | Director/Miembro de la Junta | 11/10/2013 | - |
Fundador | 11/10/2013 | - | |
Presidente | 11/10/2013 | - | |
Lexwell Partners | Fundador | 01/04/1999 | - |
Corporate Officer/Principal | 01/04/1999 | - |
Historial de carrera de Akimitsu Hirai
Antiguos cargos conocidos de Akimitsu Hirai.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | 01/03/2013 | 01/12/2014 |
Director/Miembro de la Junta | 01/12/2014 | - | |
Okinawa Protein Tomography Ltd.
Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Director/Miembro de la Junta | 01/06/2014 | - |
RAQUALIA PHARMA INC. | Director/Miembro de la Junta | 01/03/2010 | - |
Formación de Akimitsu Hirai.
University of Washington | Graduate Degree |
Keio University | Graduate Degree |
Estadísticas
Internacional
Japón | 7 |
Estados Unidos | 2 |
Operativa
Director/Board Member | 4 |
Graduate Degree | 2 |
Founder | 2 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
RAQUALIA PHARMA INC. | Health Technology |
FUNPEP COMPANY LIMITED | Health Technology |
Empresas privadas | 3 |
---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
Lexwell Partners | |
Okinawa Protein Tomography Ltd.
Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Commercial Services |
- Bolsa de valores
- Insiders
- Akimitsu Hirai
- Experiencia